Browse > Article
http://dx.doi.org/10.5483/BMBRep.2022.55.1.162

Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases  

Bang, Oh Young (Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kim, Ji-Eun (Translational and Stem Cell Research Laboratory on Stroke, Samsung Medical Center)
Publication Information
BMB Reports / v.55, no.1, 2022 , pp. 20-29 More about this Journal
Abstract
Stem cell-based therapy is a promising approach for treating a variety of disorders, including acute brain insults and neurodegenerative diseases. Stem cells such as mesenchymal stem cells (MSCs) secrete extracellular vesicles (EVs), circular membrane fragments (30 nm-1 ㎛) that are shed from the cell surface, carrying several therapeutic molecules such as proteins and microRNAs. Because EV-based therapy is superior to cell therapy in terms of scalable production, biodistribution, and safety profiles, it can be used to treat brain diseases as an alternative to stem cell therapy. This review presents evidences evaluating the role of stem cell-derived EVs in stroke, traumatic brain injury, and degenerative brain diseases, such as Alzheimer's disease and Parkinson' disease. In addition, stem cell-derived EVs have better profiles in biocompatibility, immunogenicity, and safety than those of small chemical and macromolecules. The advantages and disadvantages of EVs compared with other strategies are discussed. Even though EVs obtained from native stem cells have potential in the treatment of brain diseases, the successful clinical application is limited by the short half-life, limited targeting, rapid clearance after application, and insufficient payload. We discuss the strategies to enhance the efficacy of EV therapeutics. Finally, EV therapies have yet to be approved by the regulatory authorities. Major issues are discussed together with relevant advances in the clinical application of EV therapeutics.
Keywords
Exosomes; Extracellular vesicles; Mesenchymal stem cells; Neurodegeneration; Stroke; Traumatic brain injury;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Didiot MC, Hall LM, Coles AH et al (2016) Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing. Mol Ther 24, 1836-1847   DOI
2 Wang C, Borger V, Sardari M et al (2020) Mesenchymal stromal cell-derived small extracellular vesicles induce ischemic neuroprotection by modulating leukocytes and specifically neutrophils. Stroke 51, 1825-1834   DOI
3 Bang OY and Kim EH (2019) Mesenchymal stem cell-derived extracellular vesicle therapy for stroke: challenges and progress. Front Neurol 10, 211   DOI
4 Kalani A, Chaturvedi P, Kamat PK et al (2016) Curcuminloaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury. Int J Biochem Cell Biol 79, 360-369   DOI
5 Cha JM, Shin EK, Sung JH et al (2018) Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells. Sci Rep 8, 1171   DOI
6 Moon GJ, Sung JH, Kim DH et al (2019) Application of mesenchymal stem cell-derived extracellular vesicles for stroke: biodistribution and microRNA Study. Transl Stroke Res 10, 509-521   DOI
7 Akkoc Y and Gozuacik D (2020) MicroRNAs as major regulators of the autophagy pathway. Biochim Biophys Acta Mol Cell Res 1867, 118662   DOI
8 Jeon I, Cicchetti F, Cisbani G et al (2016) Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol 132, 577-592   DOI
9 Costa LA, Eiro N, Fraile M et al (2021) Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses. Cell Mol Life Sci 78, 447-467   DOI
10 de Almeida Fuzeta M, Bernardes N, Oliveira FD et al (2020) Scalable production of human mesenchymal stromal cell-derived extracellular vesicles under serum-/xenofree conditions in a microcarrier-based bioreactor culture system. Front Cell Dev Biol 8, 553444   DOI
11 Poo MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2, 24-32   DOI
12 Nalamolu KR, Venkatesh I, Mohandass A et al (2019) Exosomes treatment mitigates ischemic brain damage but does not improve post-stroke neurological outcome. Cell Physiol Biochem 52, 1280-1291   DOI
13 Chen CC, Liu L, Ma F et al (2016) Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol Bioeng 9, 509-529   DOI
14 Yuan D, Zhao Y, Banks WA et al (2017) Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials 142, 1-12   DOI
15 Zhao Z and Zlokovic BV (2017) Remote control of BBB: A tale of exosomes and microRNA. Cell Res 27, 849- 850   DOI
16 D'Souza A, Dave KM, Stetler RA and D SM (2021) Targeting the blood-brain barrier for the delivery of stroke therapies. Adv Drug Deliv Rev 171, 332-351   DOI
17 Ahn EH, Kang SS and Ye K (2021) Netrin-1/receptors regulate the pathogenesis in Parkinson's diseases. Precis Future Med 5, 50-61   DOI
18 Zha Y, Li Y, Lin T, Chen J, Zhang S and Wang J (2021) Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects. Theranostics 11, 397-409   DOI
19 Haney MJ, Klyachko NL, Zhao Y et al (2015) Exosomes as drug delivery vehicles for Parkinson's disease therapy. J Control Release 207, 18-30   DOI
20 Bang OY (2017) Neuroprotective strategies for acute ischemic stroke: recent progress and future perspectives. Precis Future Med 1, 115-121   DOI
21 Kordower JH and Bjorklund A (2013) Trophic factor gene therapy for Parkinson's disease. Mov Disord 28, 96-109   DOI
22 Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14, 497-500   DOI
23 Lyden PD (2021) Cerebroprotection for acute ischemic stroke: looking ahead. Stroke 52, 3033-3044   DOI
24 Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ and Pereira de Almeida L (2017) Extracellular vesicles: novel promising delivery systems for therapy of brain diseases. J Control Release 262, 247-258   DOI
25 Lee JS, Hong JM, Moon GJ et al (2010) A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099-1106   DOI
26 Chung JW, Chang WH, Bang OY et al (2021) Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke. Neurology 96, e1012-e1023   DOI
27 O'Brien CG, Ozen MO, Ikeda G et al (2021) Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: insights into the SENECA trial. JACC CardioOncol 3, 428-440   DOI
28 Brites D (2020) Regulatory function of microRNAs in microglia. Glia 68, 1631-1642   DOI
29 Otero-Ortega L, Laso-Garcia F, Frutos MCG et al (2020) Low dose of extracellular vesicles identified that promote recovery after ischemic stroke. Stem Cell Res Ther 11, 70   DOI
30 Choi Y, Kim SM, Heo Y, Lee G, Kang JY and Yoon DS (2021) Nanoelectrical characterization of individual exosomes secreted by Abeta42-ingested cells using electrostatic force microscopy. Nanotechnology 32, 025705   DOI
31 Lai RC, Tan SS, Teh BJ et al (2012) Proteolytic potential of the MSc exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012, 971907   DOI
32 Ma X, Huang M, Zheng M et al (2020) ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease. J Control Release 327, 688-702   DOI
33 Yin Z, Han Z, Hu T et al (2020) Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture. Brain Behav Immun 83, 270-282   DOI
34 Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG and Chopp M (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33, 1711-1715   DOI
35 Chen W, Zheng P, Hong T et al (2020) Astrocytes-derived exosomes induce neuronal recovery after traumatic brain injury via delivering gap junction alpha 1-20 k. J Tissue Eng Regen Med 14, 412-423   DOI
36 Elia CA, Tamborini M, Rasile M et al (2019) Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced abeta plaque burden in early stages of a preclinical model of Alzheimer's disease. Cells 8, 1059   DOI
37 Cui GH, Wu J, Mou FF et al (2018) Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice. FASEB J 32, 654-668   DOI
38 Long X, Yao X, Jiang Q et al (2020) Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury. J Neuroinflammation 17, 89   DOI
39 Soares Martins T, Trindade D, Vaz M et al (2021) Diagnostic and therapeutic potential of exosomes in Alzheimer's disease. J Neurochem 156, 162-181   DOI
40 Losurdo M, Pedrazzoli M, D'Agostino C et al (2020) Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease. Stem Cells Transl Med 9, 1068-1084   DOI
41 Cone AS, Yuan X, Sun L et al (2021) Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model. Theranostics 11, 8129-8142   DOI
42 Cui GH, Zhu J, Wang YC, Wu J, Liu JR and Guo HD (2021) Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer's disease. Mech Ageing Dev 200, 111593   DOI
43 Katsuda T, Tsuchiya R, Kosaka N et al (2013) Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3, 1197   DOI
44 Williams AM, Bhatti UF, Brown JF et al (2020) Early single-dose treatment with exosomes provides neuroprotection and improves blood-brain barrier integrity in swine model of traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg 88, 207-218   DOI
45 Haraszti RA, Miller R, Stoppato M et al (2018) Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther 26, 2838-2847   DOI
46 Wiklander OP, Nordin JZ, O'Loughlin A et al (2015) Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles 4, 26316   DOI
47 Banks WA, Sharma P, Bullock KM, Hansen KM, Ludwig N and Whiteside TL (2020) Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation. Int J Mol Sci 21, 4407   DOI
48 Li S, Stockl S, Lukas C et al (2021) Curcumin-primed human BMSC-derived extracellular vesicles reverse IL-1beta-induced catabolic responses of OA chondrocytes by upregulating miR-126-3p. Stem Cell Res Ther 12, 252   DOI
49 Hahm J, Kim J and Park J (2021) Strategies to enhance extracellular vesicle production. Tissue Eng Regen Med 18, 513-524   DOI
50 Grangier A, Branchu J, Volatron J et al (2021) Technological advances towards extracellular vesicles mass production. Adv Drug Deliv Rev 176, 113843   DOI
51 Fukuoka H and Suga H (2015) Hair regeneration treatment using adipose-derived stem cell conditioned medium: follow-up with trichograms. Eplasty 15, e10
52 Mirzaaghasi A, Han Y, Ahn SH, Choi C and Park JH (2021) Biodistribution and pharmacokinectics of liposomes and exosomes in a mouse model of sepsis. Pharmaceutics 13, 427   DOI
53 Zheng X, Hermann DM, Bahr M and Doeppner TR (2021) The role of small extracellular vesicles in cerebral and myocardial ischemia-Molecular signals, treatment targets, and future clinical translation. Stem Cells 39, 403-413   DOI
54 Khan H, Pan JJ, Li Y, Zhang Z and Yang GY (2021) Native and bioengineered exosomes for ischemic stroke therapy. Front Cell Dev Biol 9, 619565   DOI
55 Saint-Pol J, Gosselet F, Duban-Deweer S, Pottiez G and Karamanos Y (2020) Targeting and crossing the bloodbrain barrier with extracellular vesicles. Cells 9, 851   DOI
56 Kordelas L, Rebmann V, Ludwig AK et al (2014) MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28, 970-973   DOI
57 Nassar W, El-Ansary M, Sabry D et al (2016) Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 20, 21   DOI
58 Katagiri W, Osugi M, Kawai T and Hibi H (2016) First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells. Head Face Med 12, 5   DOI
59 Warnecke A, Prenzler N, Harre J et al (2021) First-inhuman intracochlear application of human stromal cell-derived extracellular vesicles. J Extracell Vesicles 10, e12094
60 Szebeni J, Muggia F, Gabizon A and Barenholz Y (2011) Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev 63, 1020-1030   DOI
61 Zhang ZG, Buller B and Chopp M (2019) Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nat Rev Neurol 15, 193-203   DOI
62 Lino MM, Simoes S, Tomatis F et al (2021) Engineered extracellular vesicles as brain therapeutics. J Control Release 338, 472-485   DOI
63 Pedrioli G, Piovesana E, Vacchi E and Balbi C (2021) Extracellular vesicles as promising carriers in drug delivery: considerations from a cell biologist's perspective. Biology (Basel) 10, 376
64 Crescitelli R, Lasser C, Szabo TG et al (2013) Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles 2, 1-10
65 Yang J, Zhang X, Chen X, Wang L and Yang G (2017) Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids 7, 278-287   DOI
66 Millan C, Prause L, Vallmajo-Martin Q, Hensky N and Eberli D (2021) Extracellular vesicles from 3D engineered microtissues harbor disease-related cargo absent in EVs from 2D cultures. Adv Healthc Mater, e2002067
67 Prasad K, Sharma A, Garg A et al (2014) Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke 45, 3618-3624   DOI
68 Zagrean AM, Hermann DM, Opris I, Zagrean L and Popa-Wagner A (2018) Multicellular crosstalk between exosomes and the neurovascular unit after cerebral ischemia. Therapeutic implications. Front Neurosci 12, 811   DOI
69 Murphy DE, de Jong OG, Brouwer M et al (2019) Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med 51, 1-12
70 Wei Z, Chen Z, Zhao Y et al (2021) Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials 275, 121000   DOI
71 Cunningham CJ, Redondo-Castro E and Allan SM (2018) The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab 38, 1276-1292   DOI
72 Park KS, Bandeira E, Shelke GV, Lasser C and Lotvall J (2019) Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 10, 288   DOI
73 Pauwels MJ, Vandendriessche C and Vandenbroucke RE (2021) Special delEVery: extracellular vesicles as promising delivery platform to the brain. Biomedicines 9, 1734   DOI
74 Wiklander OPB, Brennan MA, Lotvall J, Breakefield XO and El Andaloussi S (2019) Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 11, eaav8521   DOI
75 Zhao C, Wang H, Xiong C and Liu Y (2018) Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier. Biochem Biophys Res Commun 502, 324-331   DOI
76 Durcin M, Fleury A, Taillebois E et al (2017) Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles. J Extracell Vesicles 6, 1305677   DOI
77 Kang JY, Kim H, Mun D, Yun N and Joung B (2021) Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction. J Control Release 331, 62-73   DOI
78 Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A and Bremer N (2020) Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev 29, 747-754   DOI
79 Crewe C, Funcke JB, Li S et al (2021) Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab 33, 1853-1868 e1811   DOI
80 Nam GH, Choi Y, Kim GB, Kim S, Kim SA and Kim IS (2020) Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv Mater 32, e2002440
81 Xin H, Katakowski M, Wang F et al (2017) MicroRNA cluster miR-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke 48, 747-753   DOI
82 Xin H, Li Y, Liu Z et al (2013) MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31, 2737-2746   DOI
83 Biancone L, Bruno S, Deregibus MC, Tetta C and Camussi G (2012) Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27, 3037-3042   DOI
84 Le Saux S, Aubert-Pouessel A, Mohamed KE et al (2021) Interest of extracellular vesicles in regards to lipid nanoparticle based systems for intracellular protein delivery. Adv Drug Deliv Rev 176, 113837   DOI
85 Cai J, Wu J, Wang J et al (2020) Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential. Cell Biosci 10, 69   DOI
86 Li X, Zhang J, Zhang X and Dong M (2020) Puerarin suppresses MPP(+)/MPTP-induced oxidative stress through an Nrf2-dependent mechanism. Food Chem Toxicol 144, 111644   DOI
87 Izco M, Blesa J, Schleef M et al (2019) Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology. Mol Ther 27, 2111-2122   DOI
88 Chen HX, Liang FC, Gu P et al (2020) Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy. Cell Death Dis 11, 288   DOI
89 Karp JM and Leng Teo GS (2009) Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4, 206-216   DOI
90 Muhammad SA, Nordin N, Mehat MZ and Fakurazi S (2019) Comparative efficacy of stem cells and secretome in articular cartilage regeneration: a systematic review and meta-analysis. Cell Tissue Res 375, 329-344   DOI
91 Johnson J, Shojaee M, Mitchell Crow J and Khanabdali R (2021) From mesenchymal stromal cells to engineered extracellular vesicles: a new therapeutic paradigm. Front Cell Dev Biol 9, 705676   DOI
92 Webb RL, Kaiser EE, Scoville SL et al (2018) Human neural stem cell extracellular vesicles improve tissue and functional recovery in the murine thromboembolic stroke model. Transl Stroke Res 9, 530-539   DOI
93 Lee JY, Kim E, Choi SM et al (2016) Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke. Sci Rep 6, 33038   DOI
94 Wen S, Dooner M, Papa E et al (2019) Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a radiation injury bone marrow murine model. Int J Mol Sci 20, 5468   DOI
95 D'Souza A, Burch A, Dave KM et al (2021) Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells. J Control Release 338, 505-526   DOI
96 Loukogeorgakis SP and De Coppi P (2017) Concise review: amniotic fluid stem cells: the known, the unknown, and potential regenerative medicine applications. Stem Cells 35, 1663-1673   DOI
97 Upadhya R, Madhu LN, Attaluri S et al (2020) Extracellular vesicles from human iPSC-derived neural stem cells: miRNA and protein signatures, and anti-inflammatory and neurogenic properties. J Extracell Vesicles 9, 1809064   DOI
98 Webb RL, Kaiser EE, Jurgielewicz BJ et al (2018) Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke. Stroke 49, 1248-1256   DOI
99 Medalla M, Chang W, Calderazzo SM et al (2020) Treatment with mesenchymal-derived extracellular vesicles reduces injury-related pathology in pyramidal neurons of monkey perilesional ventral premotor cortex. J Neurosci 40, 3385-3407   DOI
100 Gao W, Li F, Liu L et al (2018) Endothelial colony-forming cell-derived exosomes restore blood-brain barrier continuity in mice subjected to traumatic brain injury. Exp Neurol 307, 99-108   DOI
101 Zhang Y, Chopp M, Zhang ZG et al (2017) Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int 111, 69-81   DOI
102 Hess DC, Wechsler LR, Clark WM et al (2017) Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 16, 360-368   DOI
103 Gholamrezanezhad A, Mirpour S, Bagheri M et al (2011) In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol 38, 961-967   DOI
104 Yang J, Wu S, Hou L et al (2020) Therapeutic effects of simultaneous delivery of nerve growth factor mRNA and protein via exosomes on cerebral ischemia. Mol Ther Nucleic Acids 21, 512-522   DOI
105 Zhang X, Liu J, Yu B, Ma F, Ren X and Li X (2018) Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes. Graefes Arch Clin Exp Ophthalmol 256, 2041-2052   DOI
106 Narbute K, Pilipenko V, Pupure J et al (2019) Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the substantia nigra and striatum of the 6-Hydroxydopamine-treated rats. Stem Cells Transl Med 8, 490-499   DOI